Mark Ledwidge

2 results

Solvotrin CEO Pat O’Flynn flanked by Prof John Gilmer of Trinity College Dublin and Prof Mark Ledwidge of UCD. Their product,  Active Iron, launched last year and was quickly snapped up by Boots

A groundbreaking iron product from Cork-based life sciences start-up Solvotrin Therapeutics looks set to disrupt the €10 billion global market for ora(...)

Pictured (l-r) are co-founders of EpiCor Therapeutics, a UCD School of  Medicine start-up: Dr Chris Watson, Dr Nadia Glezeva and Dr John Baugh,  overall winner of the 2016 UCD VentureLaunch Accelerator Programme

The development of a drug to treat devastating heart disease and a revolutionary system that cuts wound closure time after surgery by 80 per cent are (...)